Development and evaluation of vaccination strategies for addressing the continuous evolution SARS-CoV-2 based on recombinant trimeric protein technology: Potential for cross-neutralizing activity and broad coronavirus response
基于重组三聚体蛋白技术的针对持续进化的 SARS-CoV-2 的疫苗接种策略的开发和评估：具有交叉中和活性和广泛冠状病毒反应的潜力
期刊:Heliyon
影响因子:3.4
doi:10.1016/j.heliyon.2024.e34492
Peng Du, Ning Li, Shengjun Tang, Zhongcheng Zhou, Zhihai Liu, Taorui Wang, Jiahui Li, Simiao Zeng, Juan Chen
